Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy

Clinical Infectious Diseases

Volumn 27, Issue SUPPL.1, 1998, Pages

  Cornaglia, Giuseppe ^a   Ligozzi, Marco ^b   Mazzariol, Annarita ^b   Masala, Laura ^b   Lo Cascio, Giuliana ^b   Orefici, Graziella ^b   Fontana, Roberta ^b  

^a Istituto di Microbiologia   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIUM ISOLATION; CONFERENCE PAPER; ITALY; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS PYOGENES;

EID: 0031902095     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514908     Document Type: Conference Paper

References (24)

1. Duval J. Evolution and epidemiology of MLS resistance. J Antimicrob Chemother 1985;16(suppl A):137-49.
2. Järvinen H, Nissinen A, Huovinen P. Erythromycin resistance in group A streptococci. Lancet 1989;1:1022-3.
3. Stingemore N, Francis GR, Toohey M, McGeechie DB. The emergence of erythromycin resistance in Streptococcus pyogenes in Freemantle, Western Australia. Med J Aust 1989;150:626-31.
4. Seppälä H, Nissinen A, Järvinen H, et al. Resistance to erythromycin in group A streptococci. New Engl J Med 1992;326:292-7.
5. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effects of change in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New Engl J Med 1987;337:441-6.
6. Maruyama SH, Yoshioka H, Fujiita K, Takimoto M, Satake Y. Sensitivity of group A streptococci to antibiotics: prevalence of resistance to erythromycin in Japan. Am J Dis Child 1979;133:1143-5.
7. Hsueh P-R, Chen H-M, Huang A-Y, Wu J-J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 1995;39:2239-42.
8. Borzani M, Varotto F, Garlaschi L, Conio F, Dell'Olio M, Careddu P. Clinical and microbiological evaluation of miokamycin activity against group A in pediatric patients: three years' incidence of erythromycin resistant group A streptococci. J Chemother 1989;1:35-8.
9. Scopetti F, Pataracchia M, Pacifico L, et al. A multicenter study on antimicrobial susceptibility and typing of group A streptococci from cases of pharyngo-tonsillitis and scarlet fever. Microecol Ther 1995;25:348-55.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. NCCLS document M2-A6. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A4. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. NCCLS document M2-A5. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: fifth informational supplement. NCCLS document M100-S5. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1994.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: sixth informational supplement. NCCLS document M100-S6. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1995.
16. Comaglia G, Satta G. MyMic: computerised listing of antimicrobials with optimal activity and pharmacokinetic properties for individual infections. Binary 1993;5:159-64.
17. Murray BE, Singh KA, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059-63.
18. Arthur M, Brisson-Noël A, Courvalin P. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypothesis. J Antimicrob Chemother 1987;20:783-802.
19. Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 1991;10:55-7.
20. Leclerq R, Courvalin P. Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991;35:1267-72.
21. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995;39:577-85.
22. Seppälä H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993;32:885-91.
23. Leclerq R, Courvalin P. Intrinsic and unusual resistance to macrolide, lincosamide and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother 1991;35:1273-6.
24. Edmond JP, Fremaux A, Dublanchet A, et al. Resistance of two strains of Streptococcus pneumoniae to pristinamycin associated with 16-membered macrolides. Pathol Biol 1989;37:791-2.